Back to 
Vident Advisory, LLC
Vident Advisory, LLC
ADPT
Showing 1 of 5 quarters
Position history for Vident Advisory, LLC's holdings in ADAPTIVE BIOTECHNOLOGIES COR
No. Vident Advisory exited its ADPT (Adaptive Biotechnologies) position in Q3 2024. Its Q2 2024 13F listed 48,016 shares worth $173,818. Vident Advisory already held ADPT in its Q3 2023 13F, the earliest on record, and held it in 4 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History